| Ident. | Authors (with country if any) | Title |
|---|
| 000159 (2011) |
Keisuke Matsubara [Japon] ; Hiroshi Watabe [Japon] ; Yoshitaka Kumakura [Japon] ; Takuya Hayashi [Japon] ; Christopher J. Endres [États-Unis] ; Kotaro Minato [Japon] ; Hidehiro Iida [Japon] | Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: A simulation study for [18F]FDOPA PET by a model with detailed dopamine pathway |
| 000182 (2011) |
Natalie R. S. Goldberg [États-Unis] ; Tom Hampton [États-Unis] ; Scott Mccue [États-Unis] ; Ajit Kale [États-Unis] ; Charles K. Meshul [États-Unis] | Profiling changes in gait dynamics resulting from progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced nigrostriatal lesioning |
| 000289 (2011) |
Guadalupe Soria [Espagne] ; Esther Aguilar [Espagne] ; Raúl Tudela [Espagne] ; Joaquim Mullol [Espagne] ; Anna M. Planas [Espagne] ; Concepci Marin [Espagne] | In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson’s disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese‐enhanced magnetic resonance imaging in the 6‐hydroxydopamine rat model |
| 000359 (2011) |
Guangwei Du [États-Unis] ; Mechelle M. Lewis [États-Unis] ; Martin Styner [États-Unis] ; Michele L. Shaffer [États-Unis] ; Suman Sen [États-Unis] ; Qing X. Yang [États-Unis] ; Xuemei Huang [États-Unis] | Combined R2* and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease |
| 000646 (2010) |
Jiunjie Wang [Taïwan] ; Yauyau Wai [Taïwan] ; Wey-Yil Lin [Taïwan] ; Shuhang Ng [Taïwan] ; Chi-Hong Wang [Taïwan] ; Renhsiang Hsieh [Taïwan] ; Chunghuang Hsieh [Taïwan] ; Rou-Shayn Chen [Taïwan] ; Chin-Song Lu [Taïwan] | Microstructural changes in patients with progressive supranuclear palsy: A diffusion tensor imaging study |
| 000693 (2010) |
Liana G. Apostolova [États-Unis] ; Mona Beyer [Norvège] ; Amity E. Green [États-Unis] ; Kristy S. Hwang [États-Unis] ; Jonathan H. Morra [États-Unis] ; Yi-Yu Chou [États-Unis] ; Christina Avedissian [États-Unis] ; Dag Aarsland [Norvège] ; Carmen C. Janvin [Norvège] ; Jan P. Larsen [Norvège] ; Jeffrey L. Cummings [États-Unis] ; Paul M. Thompson [États-Unis] | Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia |
| 000696 (2010) |
Inbal Maidan [Israël] ; Meir Plotnik [Israël] ; Anat Mirelman [Israël, États-Unis] ; Aner Weiss [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Heart rate changes during freezing of gait in patients with Parkinson's disease |
| 000950 (2009) |
Michael D. Sage [Canada] ; Quincy J. Almeida [Canada] | Symptom and gait changes after sensory attention focused exercise vs aerobic training in Parkinson's disease |
| 000965 (2009) |
Xin Yang [Belgique] ; Birgit Mertens [Belgique] ; Enni Lehtonen [Belgique] ; Linda Vercammen [Belgique] ; Olivier Bockstael [Belgique] ; Abdelwahed Chtarto [Belgique] ; Marc Levivier [Belgique, Suisse] ; Jacques Brotchi [Belgique] ; Yvette Michotte [Belgique] ; Veerle Baekelandt [Belgique] ; Sophie Sarre [Belgique] ; Liliane Tenenbaum [Belgique] | Reversible neurochemical changes mediated by delayed intrastriatal glial cell line‐derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model |
| 000B43 (2009) |
A H Evans [Australie, Royaume-Uni] ; A D Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson’s disease |
| 000B44 (2009) |
Franz Marxreiter [Allemagne] ; Silke Nuber [Allemagne] ; Mahesh Kandasamy [Allemagne] ; Jochen Klucken [Allemagne] ; Robert Aigner [Allemagne] ; Ralf Burgmayer [Allemagne] ; Sebastien Couillard-Despres [Allemagne] ; Olaf Riess [Allemagne] ; Jürgen Winkler [États-Unis, Allemagne] ; Beate Winner [Allemagne] | Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha‐synuclein |
| 000C94 (2008) |
Eleonora Bazzini [Italie] ; Alberta Samuele [Italie] ; Marcella Granelli [Italie] ; Giovanna Levandis [Italie] ; Marie-Therese Armentero [Italie] ; Giuseppe Nappi [Italie] ; Fabio Blandini [Italie] | Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: The synergistic role of dopamine |
| 000D44 (2008) |
J. Kulisevsky [Espagne] ; J. Pagonabarraga [Espagne] ; B. Pascual-Sedano [Espagne] ; A. Gironell [Espagne] ; C. García-Sánchez [Espagne] ; M. Martínez-Corral [Espagne] | Motor changes during sertraline treatment in depressed patients with Parkinson’s disease |
| 000D46 (2008) |
Yi Wei Lu [Singapour] ; Eng-King Tan [Singapour] | Molecular biology changes associated with LRRK2 mutations in Parkinson's disease |
| 000E49 (2008) |
R. Caslake [Royaume-Uni] ; J N Moore [Royaume-Uni] ; J C Gordon [Royaume-Uni] ; C E Harris [Royaume-Uni] ; C. Counsell [Royaume-Uni] | Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism |
| 000F27 (2007) |
Fabio Blandini [Italie] ; Giovanna Levandis [Italie] ; Eleonora Bazzini [Italie] ; Giuseppe Nappi [Italie] ; Marie-Therese Armentero [Italie] | Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model |
| 000F67 (2007) |
Thomas Eckert [États-Unis, Allemagne] ; Andrew Feigin [États-Unis] ; Daniel E. Lewis [États-Unis] ; Vijay Dhawan [États-Unis] ; Steven Frucht [États-Unis] ; David Eidelberg [États-Unis] | Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging |
| 000F78 (2007) |
Yuji Nagai [Japon] ; Shigeru Obayashi [Japon] ; Kiyoshi Ando [Japon] ; Motoki Inaji [Japon] ; Jun Maeda [Japon] ; Takashi Okauchi [Japon] ; Hiroshi Ito [Japon] ; Tetsuya Suhara [Japon] | Progressive changes of pre‐ and post‐synaptic dopaminergic biomarkers in conscious MPTP‐treated cynomolgus monkeys measured by positronemission tomography |
| 001048 (2007) |
Anna Jelaso Langerveld [États-Unis] ; Daniel Mihalko [États-Unis] ; Cari Delong [États-Unis] ; Jeff Walburn [États-Unis] ; Charles F. Ide [États-Unis] | Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients |
| 001136 (2007) |
D. Grosset [Royaume-Uni] ; L. Taurah [Royaume-Uni] ; D J Burn [Royaume-Uni] ; D. Macmahon [Royaume-Uni] ; A. Forbes [Royaume-Uni] ; K. Turner [Royaume-Uni] ; A. Bowron [Royaume-Uni] ; R. Walker [Royaume-Uni] ; L. Findley [Royaume-Uni] ; O. Foster [Royaume-Uni] ; K. Patel [Royaume-Uni] ; C. Clough [Royaume-Uni] ; B. Castleton [Royaume-Uni] ; S. Smith [Royaume-Uni] ; G. Carey [Royaume-Uni] ; T. Murphy [Royaume-Uni] ; J. Hill [Royaume-Uni] ; U. Brechany [Royaume-Uni] ; P. Mcgee [Royaume-Uni] ; S. Reading [Royaume-Uni] ; G. Brand [Royaume-Uni] ; L. Kelly [Royaume-Uni] ; K. Breen [Royaume-Uni] ; S. Ford [Royaume-Uni] ; M. Baker [Royaume-Uni] ; A. Williams [Royaume-Uni] ; J. Hearne [Royaume-Uni] ; N. Qizilbash [Royaume-Uni] ; K Ray Chaudhuri [Royaume-Uni] | A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson’s disease left untreated at diagnosis |
| 001270 (2006) |
Nick Miller [Royaume-Uni] ; Emma Noble [Royaume-Uni] ; Diana Jones ; David Burn | Life with communication changes in Parkinson’s disease |
